New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
India have made significant changes to their 15-member squad for the 2026 T20 World Cup
Elmentoz Research Pvt. Ltd., a deep-tech biotechnology start-up working on precision animal nutrition and smart…
Bhubaneswar: The four-day international conference INDOCRYPT was inaugurated on Friday at the International Institute of…
Puri: The historic railway legacy of Odisha’s erstwhile garjat rulers came alive on Sunday as…
All Things Odisha hosted the 17th edition of its monthly discussion series Odisha Manaska on…
New Delhi: Union Minister for Railways, Information & Broadcasting and Electronics & Information Technology, Ashwini…
